Notice2023-17805
Supplements to Sickle Cell Disease Newborn Screening Follow-up Program Recipients (HRSA-21-036)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 18, 2023
Issuing agencies
Health and Human Services DepartmentHealth Resources and Services Administration
Abstract
HRSA will provide supplemental award funds to all 25 Sickle Cell Disease (SCD) Newborn Screening (NBS) Follow-up Program (FP) grantees for $56,000 each for fiscal year 2023. The funds will support in-scope grant activities related to health care services, increasing access to medical and social support services, and conducting outreach to help connect individuals living with SCD to follow-up care.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 159 (Friday, August 18, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 159 (Friday, August 18, 2023)]
[Notices]
[Pages 56639-56640]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-17805]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Supplements to Sickle Cell Disease Newborn Screening Follow-up
Program Recipients (HRSA-21-036)
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice of supplemental awards.
-----------------------------------------------------------------------
SUMMARY: HRSA will provide supplemental award funds to all 25 Sickle
Cell Disease (SCD) Newborn Screening (NBS) Follow-up Program
[[Page 56640]]
(FP) grantees for $56,000 each for fiscal year 2023. The funds will
support in-scope grant activities related to health care services,
increasing access to medical and social support services, and
conducting outreach to help connect individuals living with SCD to
follow-up care.
FOR FURTHER INFORMATION CONTACT: Hakim Fobia, Public Health Analyst and
Project Officer, Genetic Services Branch, Division of Services for
Children with Special Health Needs, Maternal and Child Health Bureau
(MCHB), HRSA, at <a href="/cdn-cgi/l/email-protection#b3c0d0d7c3c1dcd4c1d2dec0f3dbc1c0d29dd4dcc5"><span class="__cf_email__" data-cfemail="92e1f1f6e2e0fdf5e0f3ffe1d2fae0e1f3bcf5fde4">[email protected]</span></a> or (301) 945-9842.
SUPPLEMENTARY INFORMATION: Intended Recipients of the Award: 25 SCD NBS
FP recipients as listed in Table 1.
Amount of Non-Competitive Awards: 25 awards at $56,000 (total:
$1,400,000).
Project Period: September 1, 2023, to August 31, 2024.
CFDA Number: 93.110.
Award Instrument: Supplement.
Authority: 42 U.S.C. 701(a)(2) (Sec. 501(a)(2) of the Social
Security Act).
Table 1--Recipients and Award Amounts
----------------------------------------------------------------------------------------------------------------
Grant No. Award recipient name City, state Award amount
----------------------------------------------------------------------------------------------------------------
D1J42466.............................. Sickle Cell Disease Chicago, IL............. $56,000
Association of Illinois.
D1J42474.............................. Hemostasis and Thrombosis Las Vegas, NV........... 56,000
Center of Nevada.
D1J42475.............................. Ohio Sickle Cell & Health Columbus, OH............ 56,000
Association, Inc.
D1J42467.............................. Martin Center, Inc............ Indianapolis, IN........ 56,000
D1JMC42468............................ Baton Rouge Sickle Cell Anemia Baton Rouge, LA......... 56,000
Foundation, Inc.
D1JMC42463............................ Cayenne Wellness Center and Burbank, CA............. 56,000
Children's Foundation, Inc..
D1JMC42472............................ Children's Sickle Cell Pittsburgh, PA.......... 56,000
Foundation Inc.
D1JMC42473............................ Clark, James R Memorial Sickle Columbia, SC............ 56,000
Cell Foundation.
D1JMC42471............................ Piedmont Health Services and Greensboro, NC.......... 56,000
Sickle Cell Agency.
D1JMC42476............................ Sickle Cell Anemia Foundation Portland, OR............ 56,000
of Oregon, Inc..
D1JMC42470............................ Sickle Cell Association....... Florissant, MO.......... 56,000
D1JMC42477............................ The Sickle Cell Association Of Newark, NJ.............. 56,000
New Jersey, Inc..
D1JMC42469............................ Sickle Cell Disease Detroit, MI............. 56,000
Association of America
Michigan Chapter Inc.
D1JMC42478............................ Sickle Cell Disease Philadelphia, PA........ 56,000
Association of America
Philadelphia--Delaware Valley
Chapter.
D1JMC42462............................ Sickle Cell Foundation of Vail, AZ................ 56,000
Arizona, Inc..
D1JMC42465............................ Sickle Cell Foundation of Atlanta, GA............. 56,000
Georgia, Inc..
D1JMC42479............................ Sickle Cell Texas Marc Thomas Austin, TX.............. 56,000
Foundation.
D1JMC42480............................ Sickle Cell/Thalassemia Brooklyn, NY............ 56,000
Patients Networks, Inc..
D1JMC42481............................ Supporters of Families with Tulsa, OK............... 56,000
Sickle Cell Disease,
Incorporated.
D1JMC42464............................ University of Miami........... Miami, FL............... 56,000
D1JMC46837............................ Sickle Cell Disease Foundation Ontario, CA............. 56,000
D1JMC46836............................ Sickle Cell Disease Mobile, AL.............. 56,000
Association of America Mobile
Chapter.
D1JMC46834............................ Crescent Foundation, Inc...... Philadelphia, PA........ 56,000
D1JMC46835............................ Metropolitan Seattle Sickle Seattle, WA............. 56,000
Cell Task Force.
D1JMC46838............................ Sickle Cell Foundation of Memphis, TN............. 56,000
Tennessee.
----------------------------------------------------------------------------------------------------------------
Justification: The Consolidated Appropriations Act, 2023 (Pub. L.
117-328) provided MCHB with additional appropriations for the Sickle
Cell Disease Newborn Screening Follow-up Program. The Program currently
funds 25 community-based organizations to facilitate access to quality
SCD care. MCHB will provide a supplement of $56,000 to each of the 25
existing grantees, as outlined in Table 1. Funds will support in-scope
grant activities related to health care services, increasing access to
medical and social support services, and conducting outreach to help
connect individuals living with SCD to follow up care.
Carole Johnson,
Administrator.
[FR Doc. 2023-17805 Filed 8-17-23; 8:45 am]
BILLING CODE 4165-15-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on August 18, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.